Buy Crypto
Markets
Spot
FuturesANT
Earn
Event Center
Rewards Hub
More
100%+ PoR
AZN

AstraZeneca PLC (AZN)

NYSE
$175.79
-$3.57
(-2.00%)
Regular Market

Last updated: ⁦2026-11-19 17:25:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $175.79, with a market capitalization of $282.69B and a P/E ratio of 127.28. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$282.69B

$177.10

$178.23

$174.06

$178.76

1.42M

2.96M

127.28

$212.71

$153.41

1.25%

2026-09-30

AstraZeneca PLC (AZN) Stock Price Today

AstraZeneca PLC (AZN) is currently trading at $175.79 as of 2026-11-19 17:08:57, down 2.00% ($3.57) from the previous close of $178.76

During today's regular trading session, AZN has traded between $174.06 and $178.23, with a trading volume of 1.42M shares. The current price is near the middle of today's range.

AstraZeneca PLC (AZN) 7-Day Stock Price Change

Over the past seven days, AstraZeneca PLC (AZN) moved from $186.76 to $175.79, representing a decline of 5.87% ($10.97).

The stock traded between $174.06 and $188.10 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.95 million shares, down versus the previous seven-day period, indicating lower trading activity.

AZN 52-Week Price Position

Position in Range: 37.7%

52W Low$153.41
52W High$212.71

AZN is currently trading at $175.79, placing it 37.7% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AstraZeneca PLC (AZN)?

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

AstraZeneca PLC Information

Employees
96,100
CEO
Pascal Claude Roland Soriot
Founded
1992
Exchange
NYSE
Company Website

AZN Stock Events

View the latest dividend and stock split events for AstraZeneca PLC.

Dividend
Ex-Dividend DateAug 7, 2026
Payment DateSep 8, 2026
Dividend Per Share$0.795

AZN News

Latest news related to AstraZeneca PLC and AZN stock.

  • Benzinga

    Astrazeneca’s BLA For Sone-Ve Accepted And Granted Priority Review In US For 2nd And Later-Line Treatment Of Patients With CLDN18.2-Positive Advanced Gastric/GEJ Cancers; PDUFA Target Date Expected During Q2 Of 2027

    Based on CLARITY-Gastric01 Phase III trial results which showed Sone-Ve reduced the risk of death by 42% in this settingConsistent Sone-Ve efficacy data across CLDN18.2 expression levels (>25%) supports potential use

    Read Full Article
  • Benzinga

    FDA Accepted and Granted Priority Review to AstraZeneca’s Biologics License Application for Sonesitatug Vedotin for 2nd and Later-Line Treatment of CLDN18.2-Positive Advanced Gastric/Gastroesophageal Junction Cancers; With Regulatory Decision Anticipated In Q2 of 2027

    AstraZeneca’s Biologics License Application (BLA) for sonesitatug vedotin (Sone-Ve) has been accepted and granted Priority Review in the US for the 2nd and later-line treatment of patients with locally advanced or

    Read Full Article
  • Massive

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

    Read Full Article
  • Massive

    Pharmaceutical Market to Reach USD 3.20 Trillion by 2035 as Obesity and Oncology Drugs Lead Growth and U.S. Pricing Deals and Tariffs Reshape Manufacturing

    The global pharmaceutical market is valued at USD 1.88 trillion in 2026 and is projected to reach USD 3.20 trillion by 2035 at a CAGR of 6.10%. Growth is concentrated in obesity and oncology therapies, with U.S. pricing deals and Section 232 tariffs reshaping manufacturing. North America holds 42% of the market, while companies with strong positions in GLP-1 medicines and cancer therapies are growing significantly faster than the market.

    Read Full Article
  • Benzinga

    Tempus AI Says AstraZeneca Commits $200M In Fees Under Amended Master Services Agreement, New 5-Year Commitment Period From 1 Jan 2027

    Read Full Article

Ways to Trade AZN at MEXC

AZN MEXC RealStocks

Own real AZN shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

AZN Tokenized Stocks

Get AZN price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the AZN price
  • Trade 24/7
  • Trade on weekends and holidays

AZN Stock Futures

Trade AZN price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy AstraZeneca PLC (AZN) Stock on MEXC

Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for AZN and Place Your Order
Step 3: Search for AZN and Place Your Order
Open the RealStocks trading page and search for AZN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AstraZeneca PLC (AZN) stock price today?
AstraZeneca PLC (AZN) is currently trading at $175.79, down 2.00% ($3.57) from the previous close of $178.76. Intraday prices update in real time during regular trading hours.
2.Is AZN stock going up or down today?
As of 2026-11-19 17:08:57, AZN is trading at $175.79, down 2.00% ($3.57) from its previous close of $178.76. The stock has traded between $174.06 and $178.23 during today’s regular session. Past price movements do not guarantee future results.
3.What is AZN pre-market price?
As of 2026-11-19 17:08:57, AZN is trading at $176.77 in pre-market trading, down 1.11% ($1.99) from the previous close of $178.76. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is AZN after-hours price?
As of 2026-11-19 17:08:57, AZN is trading at $178.53 in after-hours trading, up 1.56% ($2.74) from the regular-session close of $175.79. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is AZN stock trading now?
AZN trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does AZN sit relative to its 52-week high and low?
Over the past 52 weeks, AZN has traded between a low of $153.41 and a high of $212.71. At $175.79, the stock is positioned 37.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is AstraZeneca PLC in?
AstraZeneca PLC (AZN) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is AstraZeneca PLC's market capitalization and where is it listed?
AstraZeneca PLC is listed on the NYSE exchange with a market capitalization of $282.69B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is AZN valued in terms of P/E ratio and EPS?
AZN trades at a P/E ratio of 127.28, based on trailing-twelve-month EPS of $1.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does AstraZeneca PLC pay a dividend?
AstraZeneca PLC pays an indicated annual cash dividend of $2.20 per share, with a current dividend yield of 1.25% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as AstraZeneca PLC

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AZN, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

AZN Stock Calculator

Estimate the value between AZN shares and USD.

AZN Shares to USD

AZN Shares
AZN
AZN
USD
USD
USD

1.00 AZN shares = 175.79 USD

Calculations are estimates based on the latest available price and are for reference only.